US approves new oral weight-loss pill developed by Eli Lilly
Why it matters: The FDA's approval of Foundayo provides a new oral treatment option for weight loss.
- Eli Lilly developed Foundayo, an oral weight-loss medication that just received FDA approval.
- Foundayo is now the second oral weight-loss pill to be approved by the FDA, following Novo Nordisk's Wegovy.
- The US Food and Drug Administration (FDA) granted the green light to Eli Lilly's new tablet on Wednesday.
The FDA has approved Eli Lilly's new oral weight-loss pill, Foundayo, making it the second such medication to receive regulatory clearance after Novo Nordisk's Wegovy. This approval signifies a growing landscape of pharmaceutical options for weight management, offering a tablet alternative to existing injectable treatments.
